These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 25927091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK, Hurley MN, Muhlebach MS, Smyth AR.
    Cochrane Database Syst Rev; 2013 Feb 28; (2):CD009650. PubMed ID: 23450608
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH, Bhatt J.
    Cochrane Database Syst Rev; 2016 Nov 02; 11():CD009876. PubMed ID: 27804115
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.
    López-Alcalde J, Mateos-Mazón M, Guevara M, Conterno LO, Solà I, Cabir Nunes S, Bonfill Cosp X.
    Cochrane Database Syst Rev; 2015 Jul 16; 2015(7):CD007087. PubMed ID: 26184396
    [Abstract] [Full Text] [Related]

  • 11. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.
    Regan KH, Bhatt J.
    Cochrane Database Syst Rev; 2019 Apr 18; 4(4):CD009876. PubMed ID: 30997925
    [Abstract] [Full Text] [Related]

  • 12. Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Dezube R, Jennings MT, Rykiel M, Diener-West M, Boyle MP, Chmiel JF, Dasenbrook EC.
    J Cyst Fibros; 2019 May 18; 18(3):357-363. PubMed ID: 30131297
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC, Smyth AR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD004197. PubMed ID: 19821321
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic antibiotics for cystic fibrosis.
    Smyth A, Walters S.
    Cochrane Database Syst Rev; 2001 Oct 07; (3):CD001912. PubMed ID: 11687002
    [Abstract] [Full Text] [Related]

  • 16. Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people.
    Hughes C, Smith M, Tunney M, Bradley MC.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD006354. PubMed ID: 22161402
    [Abstract] [Full Text] [Related]

  • 17. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G, Jahnke N, Remmington T.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD008319. PubMed ID: 23235659
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.
    Vanderhelst E, De Wachter E, Willekens J, Piérard D, Vincken W, Malfroot A.
    J Cyst Fibros; 2013 Dec 12; 12(6):662-6. PubMed ID: 23706641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.